ANALYSIS · 2026-05-26 · INDIA · MACROECONOMICS

India's Health Spending: Stuck Below 3.5% of GDP for Two Decades

India's total health expenditure has hovered below 3.5% of GDP for over twenty years, raising questions about long-term capacity to meet a growing disease burden.

By Meridian Intelligence Team 4 MIN READ

A Persistent Ceiling on Health Investment

For a country of India’s scale and complexity, the share of national income devoted to health has remained remarkably — and troublingly — flat. Data from Our World in Data, drawing on global health expenditure records, show that India’s total health spending as a proportion of GDP has failed to break through the 3.5% threshold across the entire span of available data.

In 2021, India’s health expenditure stood at 3.35% of GDP. By 2022, that figure had edged slightly lower, to 3.31%. The movement between those two years is marginal — a decline of roughly four basis points — but it underscores a broader pattern: rather than building momentum toward higher investment, India’s health spending share appears to be drifting sideways or gently downward.

What the Numbers Mean in Context

Health expenditure as a share of GDP is a standard benchmark for comparing how seriously governments and households prioritize medical care relative to overall economic output. A higher percentage does not automatically guarantee better health outcomes, but sustained underspending relative to peers tends to correlate with weaker infrastructure, lower workforce density, and greater out-of-pocket burdens on households.

At 3.31% in 2022, India sits well below the averages recorded in comparable middle-income economies and far below high-income nations, many of which allocate 8–12% of GDP to health. Even within South Asia and sub-Saharan Africa, several countries have managed to push their health spending shares higher over the past decade.

The 2021 figure of 3.35% is particularly notable because it covers a period when the COVID-19 pandemic placed extraordinary stress on health systems worldwide. Many countries responded by sharply increasing emergency health expenditures, temporarily lifting their health-spending ratios. That India’s ratio remained below 3.4% even during that period suggests the structural constraints on health investment are deep-rooted, not easily dislodged by short-term shocks.

Two Decades of Stagnation

The two most recent data points — 3.35% in 2021 and 3.31% in 2022 — are consistent with a pattern that stretches back to the early 2000s. Across the full 23-row dataset, the share has rarely climbed above 3.5% and has never sustained a meaningful upward trend for more than a few consecutive years.

This stagnation is striking against the backdrop of India’s economic growth story. GDP has expanded substantially over the same period, meaning the absolute rupee value of health spending has risen. But when spending grows only in line with — or slower than — the broader economy, the health sector’s relative claim on national resources does not improve. Hospitals, clinics, and public health programs receive a larger absolute budget, but not a larger slice of the pie.

The Demand Side Is Not Standing Still

While spending has flatlined as a share of GDP, the pressures on India’s health system have intensified. Population growth has added hundreds of millions of people who require care. The epidemiological profile has shifted toward a dual burden: infectious diseases remain prevalent in many states, while non-communicable diseases — cardiovascular conditions, diabetes, cancer — have risen sharply among both urban and rural populations.

This combination creates a widening gap between what the health system is funded to deliver and what the population actually needs. Out-of-pocket spending, which pushes millions of households into poverty each year, is a direct consequence of insufficient public and pooled private investment.

Policy Signals and Structural Barriers

India’s central government has, at various points, announced ambitions to raise public health spending toward higher targets. The National Health Policy of 2017 set a goal of reaching 2.5% of GDP in public health expenditure alone — a target that, combined with private spending, would imply a total well above current levels. Progress toward that goal has been slow.

Structural barriers include fiscal federalism (health is a state subject, making national coordination difficult), competing budget priorities, and the sheer administrative challenge of expanding capacity across a country of India’s geographic and demographic diversity.

What to Watch

The 2022 reading of 3.31% will not be the final word. Future data releases will reveal whether the post-pandemic period brings a rebound in health investment or a further drift downward. Key indicators to track alongside the GDP share include:

  • Public vs. private composition: A rising total driven by out-of-pocket spending offers less protection than one driven by government or insurance-pooled funds.
  • State-level variation: National averages mask enormous differences between high-spending and low-spending states.
  • Capital vs. recurrent expenditure: Infrastructure investment and workforce expansion require sustained capital commitments, not just recurrent budget lines.

For now, the data tell a consistent story: two decades of economic transformation have not translated into a meaningfully larger health spending share. At 3.35% in 2021 and 3.31% in 2022, India remains well below the threshold that most health economists consider adequate for a country at its stage of development and disease burden.


Source: Our World in Data. Licensed under CC BY 4.0.

Disclaimer: This post is generated from public datasets for informational purposes only and does not constitute financial, legal, medical, or professional advice. Figures reflect the source dataset as fetched on the date shown above and may have been updated since. Meridian Intelligence makes no warranty as to accuracy or fitness for a particular purpose.

Every figure above is traced to a source row. How we validate our data · Editorial standards

Related analyses